Glucomoringin (Rhamnosylated Aromatic Glucosinolate · Moringa · Anti-inflammatory)
| Compound | Glucomoringin (GMG) |
| Chemical class | Glucosinolate — Aromatic (4-α-L-Rhamnosyloxybenzyl glucosinolate) |
| CAS | (no universal CAS; synonymous with moringa glucosinolate) |
| Primary source | Moringa oleifera (drumstick tree, Sahjan) leaves and seeds |
| Key applications | MIC-1 isothiocyanate precursor, anti-inflammatory, antioxidant, immunomodulatory, antibacterial |
| Claim strength | Moderate |
| Typical form | Moringa leaf extract (glucomoringin co-constituent); moringa seed extract |
| Buy from Herbuno |
Dehydrated Moringa Leaf Powder | Sahjan → Moringa Oleifera Leaf Extract Powder | Sahjan → |
Name origin: From Moringa oleifera. Glucomoringin is the unique rhamnosylated benzyl glucosinolate of moringa — structurally distinct from simple glucotropaeolin (benzyl glucosinolate) in having a 4-α-L-rhamnose sugar attached to the benzyl ring’s para position. This rhamnosylation is unique to Moringa and its glucosinolates. Myrosinase hydrolysis generates 4-α-L-rhamnosyloxybenzyl isothiocyanate (rhMIC-1), which can further cyclise to 4-α-L-rhamnosyloxybenzyl isothiocyanate or the corresponding thiocyanate under different pH conditions. Traditional use: Moringa (Sahjan in Hindi, Shigru in Ayurveda, Drumstick tree) is one of the most nutritionally dense plants known — all parts (leaves, seeds, pods, bark, roots) have been used in Ayurvedic medicine for over 4,000 years for infections, inflammation, anaemia, malnutrition, and as a potent anti-inflammatory. In traditional Indian medicine, Moringa is called “the miracle tree” or “the tree of life.” Glucomoringin is the primary glucosinolate and contributes to moringa’s antimicrobial and anti-inflammatory traditional applications. Research trajectory: Glucomoringin has documented anti-inflammatory (NF-κB inhibition by rhMIC-1), antibacterial, antioxidant, and immunomodulatory properties. The unique rhamnosylated isothiocyanate generated from glucomoringin shows selectivity for cancer cells in some comparisons. Commercial source: Moringa Oleifera Leaf Extract Powder and Dehydrated Moringa Leaf Powder from Herbuno. See sourcing options below.
Evidence for Glucomoringin Applications
Anti-inflammatory via rhMIC-1: The isothiocyanate generated from glucomoringin (4-α-L-rhamnosyloxybenzyl isothiocyanate, rhMIC-1) inhibits NF-κB and reduces production of TNF-α, IL-6, and IL-1β in macrophage models at low micromolar concentrations. This is considered the primary molecular mechanism behind moringa’s well-documented anti-inflammatory activity. Claim strength: Moderate.
Antibacterial: RhMIC-1 and intact glucomoringin demonstrate antibacterial activity against S. aureus, E. coli, Helicobacter pylori, and Mycobacterium tuberculosis in in vitro assays. The rhamnosylated structure may contribute to improved membrane penetration and bacterial selectivity. Claim strength: Moderate.
Antioxidant and Nrf2 activation: Glucomoringin and its hydrolysis products activate Nrf2 and induce Phase-II detoxification enzymes, contributing to moringa’s documented antioxidant activity. The rhamnosylated benzyl isothiocyanate has effective Nrf2 activation potency. Claim strength: Moderate.
Nutritional context — moringa’s multifaceted profile: Moringa leaf is one of the most nutritionally dense foods known — high protein (25–35% dry weight), vitamin C, beta-carotene, iron, calcium, and potassium. The nutritional value of moringa (relevant to its traditional use for malnutrition) operates alongside glucomoringin’s pharmacological activity. For supplement formulations, moringa’s combined nutritional and phytochemical profile is a key differentiating factor. Claim strength: High (nutritional claims); Moderate (glucomoringin-specific pharmacological claims).
Dehydrated Moringa Leaf Powder | Sahjan →
Moringa Oleifera Leaf Extract Powder | Sahjan →
Browse Standardised Extract Powders →
Dosage & Formulator Specification
Human clinical data for moringa preparations (not isolated glucomoringin): 7 g/day moringa leaf powder for blood glucose management (one RCT); 6 g/day for lipid-lowering effects; traditional nutritional doses of 50–100 g fresh moringa leaves/day. Glucomoringin content in moringa leaf: approximately 0.1–1% of dry leaf weight (variable by growing conditions and processing). Moringa leaf is heat-sensitive — myrosinase is inactivated during drying at high temperatures, preserving glucomoringin in stable form with conversion to rhMIC-1 occurring via gut microbiota. For maximum glucomoringin conversion, use low-temperature dried moringa leaf extract or pair with exogenous myrosinase. Request HPLC glucosinolate profile on CoA alongside nutritional analysis.
Frequently Asked Questions — Glucomoringin
What makes moringa glucosinolates unique compared to other Brassica glucosinolates?
Moringa’s glucosinolates are uniquely rhamnosylated — the rhamnose sugar attached to the benzyl ring is not found in any other commercially significant glucosinolate-containing plant. This rhamnosylation affects the water solubility, stability, and hydrolysis kinetics of glucomoringin differently from standard benzyl or aliphatic glucosinolates. The resulting isothiocyanate (rhMIC-1) also has a distinct pharmacological profile compared to BITC (simple benzyl isothiocyanate from glucotropaeolin), with some studies suggesting greater cancer cell selectivity and different enzyme inhibition patterns.
Is moringa leaf extract the same as moringa seed extract for glucomoringin?
Both contain glucomoringin, but at different concentrations and with different co-constituent profiles. Moringa seeds have higher glucomoringin content per gram than leaves (seeds may contain 5–10× more glucosinolate per gram). Moringa leaf extract has the nutritional advantage (vitamins, minerals, protein, carotenoids) alongside glucomoringin. For isolated glucomoringin activity, seed extract provides higher concentration; for the complete moringa nutritional-pharmacological profile, leaf extract is appropriate.
Can moringa be used in infant or paediatric nutrition supplements?
Moringa leaf powder is used in paediatric malnutrition programmes in multiple developing countries (USAID and WHO-supported programmes in Africa and Asia) as a safe, affordable, nutrient-dense supplement for children under 5 years. At food-level doses (1–10 g/day dried leaf powder) it is considered safe for paediatric use. For Western supplement markets, standard paediatric supplement regulatory frameworks apply. The glucomoringin content at food doses is within safe ranges; isolated glucomoringin has not been specifically evaluated for paediatric dosing.
Does moringa have significant blood glucose-lowering effects?
Yes — moringa has multiple mechanisms relevant to blood glucose management: chlorogenic acids (glucose transporter inhibition), quercetin (GLUT4 upregulation), isothiocyanates from glucomoringin (AMPK activation), and direct alpha-glucosidase inhibition. An RCT in healthy adults (Thapar et al.) demonstrated 21% reduction in post-prandial blood glucose from 7 g moringa leaf powder added to a meal. Diabetes-specific supplement claims require additional clinical evidence but the mechanistic basis is well-established.
Related compounds: Glucotropaeolin, Gluconasturtiin, Glucoraphanin, Sulforaphane
Claim-strength scale – High = multiple human RCTs; Moderate = limited trials or strong preclinical convergence; Emerging = early-stage lab or animal data.
← HerbIQ Compound Index · HerbIQ P02: Extraction · HerbIQ P03: Delivery